What is LOPJLB’s current signal on HURA?

LOPJLB’s latest quantitative signal on TuHURA Biosciences, Inc. (HURA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is HURA in?

TuHURA Biosciences, Inc. (HURA) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does TuHURA Biosciences, Inc. (HURA) do?

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.

Where is TuHURA Biosciences, Inc. based / listed?

TuHURA Biosciences, Inc. is based in US, listed on NASDAQ.

TuHURA Biosciences, Inc. (HURA)

Healthcare · Biotechnology · NASDAQ · US

$2.15+7.50%Close

SELLCRISIS · day 5

[SCORES & PROFILE]

FUND: 15
VALUE: 1
GROWTH: 43
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-92.6%

REV YoY-

ROE-154.3%

EPS YoY-

ROA-96.5%

GROSS

NET

[VALUATION]

P/E TTM-3.98

P/E FWD-

SECTOR PE22.66

INDUSTRY PE17.07

P/B7.43

P/FCF-

EV/EBITDA-4.64

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E2.20

ALTMAN Z-

CURR RATIO0.18

ND/EBITDA-

BETA-0.01

TuHURA Biosciences, Inc. (HURA)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news